| 000 | 01728 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514213021.0 | ||
| 264 | 0 | _c20050519 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a1073-2322 | ||
| 024 | 7 |
_a10.1097/01.shk.0000144422.32647.b6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIba, Toshiaki | |
| 245 | 0 | 0 |
_aAssociation between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers. _h[electronic resource] |
| 260 |
_bShock (Augusta, Ga.) _cJan 2005 |
||
| 300 |
_a25-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAntithrombin III |
| 650 | 0 | 4 |
_aAntithrombins _xbiosynthesis |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aBlood Cell Count |
| 650 | 0 | 4 | _aBlood Coagulation Tests |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrin _xbiosynthesis |
| 650 | 0 | 4 |
_aFibrin Fibrinogen Degradation Products _xbiosynthesis |
| 650 | 0 | 4 | _aHemostasis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeptide Hydrolases _xblood |
| 650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xblood |
| 650 | 0 | 4 | _aROC Curve |
| 650 | 0 | 4 |
_aSepsis _xblood |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aalpha-2-Antiplasmin _xbiosynthesis |
| 700 | 1 | _aKidokoro, Akio | |
| 700 | 1 | _aFukunaga, Masaki | |
| 700 | 1 | _aSugiyama, Kazuyoshi | |
| 700 | 1 | _aSawada, Tomohiro | |
| 700 | 1 | _aKato, Hisaaki | |
| 773 | 0 |
_tShock (Augusta, Ga.) _gvol. 23 _gno. 1 _gp. 25-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.shk.0000144422.32647.b6 _zAvailable from publisher's website |
| 999 |
_c15295648 _d15295648 |
||